Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Rituximab plus intravenous bolus chemotherapy is a standard treatment for immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL). Some studies have suggested that rituximab is associated with excessive toxicity in HIVassociated NHL, and that infusional chemotherapy may be more effective. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sparano, Joseph A., Lee, Jeannette Y., Kaplan, Lawrence D., Levine, Alexandra M., Ramos, Juan Carlos, Ambinder, Richard F., Wachsman, William, Aboulafia, David, Noy, Ariela, Henry, David H., Von Roenn, Jamie, Dezube, Bruce J., Remick, Scot C., Shah, Manisha H., Leichman, Lawrence, Ratner, Lee, Cesarman, Ethel, Chadburn, Amy, Mitsuyasu, Ronald
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858478/
https://ncbi.nlm.nih.gov/pubmed/20023215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-08-231613
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados